ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672305; 2) Community: the network communities that were significantly associated with the response to NSC 672305; 3) Molecule: the relationships between components within communities and NSC 672305; 4) MDR: the compounds that were significantly associated with the NSC 672305.

NSC Compound Enrichment Correlation
NSC 680410 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) 0.0286383688883671 0.45414813
NSC 68093 Null 0.0286383688883671 0.45964254
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.0286383688883671 0.47451131
NSC 687011 stereoisomer of 672120 (MW=262) 0.0286383688883671 0.54656162
NSC 710342 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyophenyl)-5,7-dihydroxy-3,6,8-tris(3-methyl-2-butenyl)- (9CI) 0.0286383688883671 0.40180747
NSC 740252 Null 0.0286383688883671 0.38185153
NSC 763587 Null 0.0286383688883671 0.47314745
NSC 253272 Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) 0.0291420747327558 0.53062564
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0291420747327558 -0.0117679
NSC 622924 Null 0.0291420747327558 -0.13235354
Total:98  Current:63    [First] [Prev] [Next] [Last]